Article Per Year (5 Year)
p-Index From 2020 - 2025
1.151
P-Index
This Author published in this journals
All Journal Buletin Ilmiah Nagari Membangun Eureka Herba Indonesia Jurnal Pengabdian Kepada Masyarakat Ceria
Yohana Suganda
Universitas Sumatera Barat
Agriculture, Biological Sciences & Forestry Humanities Computer Science & IT Economics, Econometrics & Finance Education Engineering Environmental Science Health Professions Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Mathematics Medicine & Pharmacology Nursing Public Health Social Sciences Veterinary Other

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Eureka Herba Indonesia

 1 
The Effect of Topical Virgin Coconut Oil on Striae Gravidarum Prevention and Severity: A Randomized Controlled Trial Ulya, Rahmatul; Sunesni; Yohana Suganda; Mekar Zenni Radhia
Eureka Herba Indonesia Vol. 5 No. 3 (2024): Eureka Herba Indonesia
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/ehi.v5i3.124

Abstract

Striae gravidarum (SG), commonly known as stretch marks, is a common concern during pregnancy. Virgin coconut oil (VCO) is traditionally used for skin health and may have potential in SG prevention. This randomized controlled trial (RCT) aimed to assess the efficacy of topical VCO in preventing and reducing the severity of SG among pregnant women in Kerinci Regency, Indonesia. Pregnant women (n=200) in their second trimester were randomized to receive either topical VCO or a placebo (standard emollient) twice daily. SG severity was assessed using a modified striae gravidarum assessment scale (SGAS) at baseline, 32 weeks gestation, and six weeks postpartum. VCO application was associated with a significantly lower incidence of new SG compared to the placebo (25% vs. 45%, p < 0.05). Furthermore, the VCO group showed a significant reduction in SG severity at 32 weeks and postpartum (mean SGAS scores: VCO 1.8 vs. placebo 2.6 at 32 weeks, p < 0.05; VCO 1.4 vs. placebo 2.2 at postpartum, p < 0.01). No adverse effects were reported. In conclusion, topical VCO appears to be safe and effective in preventing new SG and reducing the severity of existing SG during pregnancy. Further research is warranted to explore the underlying mechanisms and long-term effects.
Co-Authors Dewi Asmawati Elwitri Silvia Mekar Zenni Radhia Novia Rita Sunesni . Ulya, Rahmatul Welly Handayani